A recent Wall Street Journal report, released on February 3, sheds light on Elon Musk’s influence at SpaceX, Tesla, and X (previously Twitter).
It touches on the embedded drug use within Musk’s circle, which has raised eyebrows among company executives.
This follows earlier concerns voiced in January about illicit substance consumption.
The narrative suggests that avoiding drugs might alienate Musk from his executives. This fear looms large, as maintaining a close relationship with Musk is seen as valuable.
The report lists substances like Ecstasy, LSD, mushrooms, and Ketamine as Musk’s preferences during private events and vacations.
Attendees often include high-profile names such as:
Joe Gebbia of Airbnb,
– Antonio Gracias of Valor Equity Partners,
– Steve Jurvetson of Future Ventures, and
– Kimbal Musk, a significant Tesla shareholder.
This behavior starkly contrasts with the strict anti-drug policies at Musk’s companies and could endanger SpaceX’s federal contracts and Musk’s security clearances.
Despite awareness of Musk’s drug use, both current and former executives hesitate to address it publicly.
No comments have been made by Musk or his attorney, Alex Spiro, regarding these reports.
Understanding this situation is vital as it highlights the clash between personal lifestyles and professional obligations.
It raises questions about leadership influence and the potential risks to company integrity and legal compliance.
Background
Ecstasy, or MDMA, enhances pleasure and connection but poses risks like dehydration and cognitive impairments.
LSD, a potent hallucinogen, can dramatically shift perception, sometimes causing distressing “bad trips” and psychological effects.
Psilocybin in “magic mushrooms” triggers vivid hallucinations and time distortion, yet it might lead to nausea and panic.
Ketamine offers dissociative experiences but risks memory issues and bladder damage with long-term use.
These substances can have therapeutic benefits but also carry significant health risks.
The balance between their potential for insight and harm varies based on dosage, usage context, and individual reaction.
It’s crucial to consider these factors and the possibility of misuse before engaging with any of these drugs.
This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error